Synthesis, biological evaluation, and baboon PET imaging of the potential adrenal imaging agent cholesteryl-p-[18F]fluorobenzoate

Nuclear Medicine and Biology

Volumn 26, Issue 1, 1999, Pages 131-138

  Jonson, Stephanie D ^a,b   Welch, Michael J ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Adrenal imaging; Cholesterol; Cholesteryl fluorobenzoate; Fluorine 18; Positron emission tomography

Indexed keywords

BENZOIC ACID DERIVATIVE; CHOLESTEROL ESTER; CHOLESTERYL 4 FLUOROBENZOATE F 18; FLUORINE 18; UNCLASSIFIED DRUG;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; DRUG DISTRIBUTION; DRUG SYNTHESIS; FEMALE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; RAT; TISSUE DISTRIBUTION;

ADRENAL GLANDS; ANIMALS; BENZOATES; CHOLESTEROL ESTERS; FEMALE; FLUORINE RADIOISOTOPES; KIDNEY; OVARY; PAPIO; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN; TISSUE DISTRIBUTION; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0032939817     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(98)00081-X     Document Type: Article

References (45)

1. Allen L.A., Spratt M.P., Glass T.E., Dorn H.C. Directly coupled liquid chromatography/fluorine-19 Fourier transform nuclear magnetic resonance. Anal. Chem. 60:1988;675-679.
2. Andersen J.M., Dietschy J.M. Relative importance of high and low density lipoproteins in the regulation of cholesterol synthesis in the adrenal gland, ovary, and testis of the rat. J. Biol. Chem. 253:1978;9024-9032.
3. 18F]fluoride ion. A new route to aryl fluorides of high specific activity. J. Chem. Soc., Chem. Commun., 108.
4. -. J. Labelled Compd. Radiopharm. 20:1983;501-514.
5. 131I-19-iodocholesterol Effects of thyroid blocking agents . J. Clin. Endocrinol. Metab. 41:1975;405-407.
6. Beenaker C.I.M. A cavity for microwave-induced plasmas operated in helium and argon at atmospheric pressure. Spectrochim. Acta. 31B:1976;483-486.
7. Beierwaltes W.H., Wieland D.M., Yu T., Swanson D.P., Mosley S.T. Adrenal imaging agents Rationale, synthesis, formulation, and metabolism . Semin. Nucl. Med. 8:1978;5-21.
8. Brown M.S., Goldstein J.L. Regulation of the activity of the low density lipoprotein receptor in human fibroblasts. Cell. 6:1975;307-316.
9. Brown M.S., Goldstein J.L. Receptor-mediated control of cholesterol metabolism. Science. 191:1976;150-154.
10. Bui F., Macri' C., Varotto L., Boscaro M., Mantero F. Adrenal scintigraphy in the morphological and functional evaluation of Cushing's syndrome. Cardiology. 72:(suppl. 1):1985;76-83.
11. Carey J.E., Thrall J.H., Freitas J.E., Beierwaltes W.H. Absorbed dose to the human adrenals from iodomethylnorcholesterol (I-131) "NP-59" Concise communication . J. Nucl. Med. 20:1979;60-62.
12. Chatal J.F., Charbonnel B., Guihard D. Radionuclide imaging of the adrenal glands. Clin. Nucl. Med. 3:1978;71-76.
13. Counsell R.E., Ranade V.V., Kulkarni P.G., Afiatpour P. Potential organ or tumor-imaging agents. 12. Esters of 19-radioiodinated cholesterol. J. Nucl. Med. 14:1973;777-780.
14. Counsell R.E., Schwendner S.W., Gross M.D., Longino M.A., McConnell D.S. Lipoprotein incorporation enhances radioiodinated cholesteryl ester uptake into steroid hormone-secreting tissues. J. Nucl. Med. 30:1989;1088-1094.
15. Counsell R.E., Seevers R.H., Korn N., Schwendner S.W. Potential organ- or tumor-imaging agents. 21. Acyl-labeled esters of cholesterol. J. Med. Chem. 24:1981;5-6.
16. Dence C.S., Mishani E., McCarthy T.J., Welch M.J. Evaluation of a microwave cavity for the synthesis of PET radiopharmaceuticals. J. Labelled Compd. Radiopharm. 37:1995;115-117.
17. 131I-19-Iodocholesterol scintigraphy of the adrenal cortex. Acta Endocrinol. 80:1975;81-94.
18. Gross M.D., Shapiro B., Francis I.R., Glazer G.M., Bree R.L., Arcomano M.A., Schteingart D.E., McLeod M.K., Sanfield J.A., Thompson N.W. Scintigraphic evaluation of clinically silent adrenal masses. J. Nucl. Med. 35:1994;1145-1152.
19. Gross M.D., Shapiro B., Freitas J.E., Ayers J., Swanson D.P., Woodbury M.C., Schteingart D.E., Beierwaltes W.H. The relationship of I-131 6β-iodomethyl-19-norcholesterol (NP-59) adrenal cortical uptake to indices of androgen secretion in women with hyperandrogenism. Clin. Nucl. Med. 9:1984;264-270.
20. Gross M.D., Valk T.W., Swanson D.P., Thrall J.H., Grekin R.J., Beierwaltes W.H. The role of pharmacologic manipulation in adrenal cortical scintigraphy. Semin. Nucl. Med. 11:1981;128-148.
21. Haradahira T., Schwendner S.W., Kojima M., Counsell R.E. Potential tumor- or organ-imaging agents. 29. Radioiodinated esters and amides of 20-hydroxy- and 20-aminopregn-5-en-3β-ols. J. Med. Chem. 32:1989;609-612.
22. Harris R.D., Herwig K.R. Unusual cause for recurrent Cushing syndrome and its diagnosis by computed tomography and NP-59 radiocholesterol scanning. Urology. 36:1990;277-279.
23. Hawkins L.A., Britton K.E., Shapiro B. Selenium-75 selenomethyl cholesterol A new agent for quantitative functional scintigraphy of the adrenals: Physical aspects . Br. J. Radiol. 53:1980;883-889.
24. Kannan C.R. Diseases of the adrenal cortex. Disease-A-Month. 34:1988;601-674.
25. Kaplan S.A. Disorders of the adrenal cortex I. Pediatr. Clin. North Am. 26:1979;65-76.
26. Kazerooni E.A., Sisson J.C., Shapiro B., Gross M.D., Driedger A., Hurwitz G.A., Mattar A.G., Petry N.A. Diagnostic accuracy and pitfalls of [iodine-131]6-beta-iodomethyl-19-norcholesterol (NP-59) imaging. J. Nucl. Med. 31:1990;526-534.
27. 131I-19-iodocholesterol The pitfalls of using tissue concentration data . J. Nucl. Med. 19:1975;149-153.
28. Kojima M., Maeda M., Ogawa H., Nitta K., Ito T. New adrenal-scanning agent. J. Nucl. Med. 16:1975;666-668.
29. Kovanen P.T. Regulation of plasma cholesterol by hepatic low-density lipoprotein receptors. Am Heart J. 113:1987;464-469.
30. 131I-19-iodocholesterol. N. Engl. J. Med. 285:1971;1387-1393.
31. Miller J.L., Smith J.A., Mervis B. Quantitative selenium-75-cholesterol imaging and computed tomography of the adrenal glands in Conn's syndrome. S. Afr. Med. J. 62:1982;693-695.
32. Miller J.L., Smith J.A., Mervis B., Roman T. Selenium-75-cholesterol imaging and computed tomography of the adrenal glands in differentiating the cause of Cushing's syndrome. S. Afr. Med. J. 63:1983;848-850.
33. Moses D.C., Schteingart D.E., Sturman M.F., Beierwaltes W.H., Ice R.D. Efficacy of radiocholesterol imaging of the adrenal glands in Cushing's syndrome. Surg. Gynecol. Obstet. 139:1974;201-204.
34. Ross E.J. Cushing's syndrome Current status . Cardiology. 72:(suppl. 1):1985;64-69.
35. Rudling M.J. Role of the liver for the receptor-mediated catabolism of low-density lipoprotein in the 17α-ethinylestradiol-treated rat. Biochim. Biophys. Acta. 919:1987;175-180.
36. Sarkar S.D., Beierwaltes W.H., Ice R.D., Basmadjian G.P., Hetzel K.R., Kennedy W.P., Mason M.M. A new and superior adrenal scanning agent, NP-59. J. Nucl. Med. 16:1975;1038-1042.
37. Seevers R.H., Groziak M.P., Weichert J.P., Schwendner S.W., Szabo S.M., Longino M.A., Counsell R.E. Potential tumor or organ-imaging agents. 23. Sterol esters of iopanoic acid. J. Med. Chem. 25:1982;1500-1503.
38. Seevers R.H., Schwendner S.W., Swayze S.L., Counsell R.E. Potential organ or tumor-imaging agents. 22. Acyl-labeled cholesterol esters. J. Med. Chem. 25:1982;618-621.
39. 75Se selenomethylcholesterol adrenal imaging. Clin. Endocrinol. 15:1981;19-27.
40. Spratt M.P., Meng Y., Dorn H.C. Characterization of amino acids and steroids by fluorine-19 Nuclear Magnetic Resonance spectrometry of p-fluorobenzoyl derivatives. Anal. Chem. 57:1985;76-81.
41. Thomson D.M., Dovey P., Davis J.B. Visualization of abnormal adrenal uptake of 19-iodocholesterol in Conn's syndrome. Br. J. Radiol. 51:1978;545-546.
42. 131I-19-iodocholesterol. Br. J. Radiol. 50:1977;340-349.
43. VanDort M., Santay L., Schwendner S.W., Counsell R.E. Potential tumor or organ imaging agents. 31. Radioiodinated sterol benzoates and carbamates. Nucl. Med. Biol. 16:1989;603-607.
44. VanDort M., Schwendner S.W., Counsell R.E. Potential tumor or organ-imaging agents. 28. Radioiodinated esters of cholesterol and pregnenolone. Steroids. 49:1987;531-541.
45. VanDort M., Schwendner S.W., Skinner R.W.S., Gross M.D., Counsell R.E. Potential tumor or organ-imaging agents. 24. Radioiodinated pregnenolone esters. Steroids. 44:1984;85-93.